Walleye Capital’s Achieve Life Sciences QUIT Stock Holding History
Bought
Maintained
Sold
Other funds holding QUIT
ACM
Walleye Capital's QUIT Position: Q1 2024 in Review
Walleye Capital sold out of Achieve Life Sciences (QUIT) in Q1 2024, closing a stake of 82,599 shares — an estimated $340K sold.
Walleye Capital first reported a position in QUIT in Q3 2018 and held it in 6 quarters. The position peaked at $493K in Q2 2023. 41 funds tracked by Wall St. Rank hold QUIT as of Q1 2024.
- Walleye Capital reported no remaining Achieve Life Sciences position as of Q1 2024 after selling out during the quarter.
- Walleye Capital sold 82,599 Achieve Life Sciences shares in Q1 2024, an estimated $340K.
- Walleye Capital first reported a position in Achieve Life Sciences in Q3 2018 and held it in 6 quarters.
- Walleye Capital's Achieve Life Sciences position peaked at $493K in Q2 2023.
- 41 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2024.
Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.